How to build the innovation center from the lab research to commercialization?

  From Silicon Valley to Tel Aviv, from the Yangtze River Delta to Guangdong, Hong Kong and Macao, new technological breakthroughs have accelerated the industrial transformation. The development of cities and urban agglomerations is undergoing profound changes.
  Shanghai is deeply implementing the innovation-driven development strategy. It have become a top priority to accelerate the construction of a globally influential science and technology innovation center under the situation of the Yangtze River Delta integration.
  Technology will ultimately have an impact on human life and change the way people live, and this will inevitably require commercialization and marketization. However, all leading technologies originate from basic research. Without basic research, there will be no subsequent technology generation, and there will be no subsequent marketization. Zhang Wei, the global senior partner of the Anbai Shen Equity Investment Group and the president of Greater China, and the founding director of the Future Forum, said in an interview with the First Financial Times.
  It’s a long way from lab research to commercialization.
  Explore a new way of transforming industry-university-research cooperation
  The university that has abundant scientific research strength is always the cradle of frontier science and technology.
  In terms of research and commercialization, Liu Xiaole, a tenured professor of statistics, biostatistics and computational biology at Harvard University and Dana-Farber Cancer Institute, and director of the Dana-Farber Center for Functional Cancer Epigenetics, is exploring.
  Her research interests are related to the CRISPR genome-wide screening technology. CRISPR, in simple terms, when bacteria are infected with a virus, they have a unique solution: retain a portion of the virus's DNA and identify it with a system called CRISPR in the body. If you see these infected DNA fragments again, cut them off. Similarly, DNA in human cells can be composed of four bases abbreviated as A, T, C, and G. CRISPR can cut or edit these bases.
  Nowadays, the development and utilization of this technology is far from entering the real therapeutic field. "After the patient has been sequenced, the expectation is very high. We know that some genetic variants still can't find the available drugs, just the genetic variants that can be used for treatment. Now there are these targeted therapies. Can relieve cancer for a period of time." Liu Xiaole said.
  In order to promote the commercialization of research results, Liu Xiaole, as the founder and scientific consultant and student, established Shanghai Xund Baihui Biotechnology Co., Ltd. in ZhangJiang, Shanghai. At present, the team has established a CRISPR screening experimental workflow and data analysis process. The application of CRISPR genome-wide screening to discover new targets, biomarkers and construct new combination therapies can advance the development speed and accuracy of cancer treatment methods. Accelerate the research and development efficiency of the cancer treatment drug development industry.
  "I hope to make it a platform." Liu Xiaole told the China Business Network that startup company also helped the research.
  The attempt to turn some technical inventions at universities into patents and even further commercialization was recognized by Curium founder and CEO Hanan Terkel. At the “Pujiang Innovation Forum – 2018 International Symposium on Science and Technology Think Tanks” hosted by the Shanghai Institute for Science of Science, Hanan introduced Israel’s approach to CBN: there will be a special “Transformation Office” in Israeli universities. This is a private company with school authorization. When professors have a good invention and want to commercialize, the transformation office will help them complete the patent application and further clarify the property rights. In this process, you can also use the university’s interdisciplinary mobilization resources, such as the business school to complete the design of the business plan, or the engineering school to complete the product design.
  Referring to industry-university-research cooperation, Hanan said that he values the flow of talent. “The mobility of talent is very important. People can choose to start a business. If they fail, they can go back to work in a big company and worry that failure is the biggest obstacle to innovation.” And the Israeli professor can have two years of “departed entrepreneurship”. This flow provides institutional guarantees, and if the professor is willing to return to school afterwards, he can still serve as a consultant for the company.
  Of course, the most needed in conversion of these technologies is time.
  Respect other innovation center models rationally
  Although some well-known innovation centers have achieved good results, others are more concerned about the changes that the Innovation Center has brought to the development of the region.
  In the eyes of Silicon Valley co-investment chairman and CEO Russell Hancock, Silicon Valley has had its own problems, such as overwhelmed high prices, crowded traffic and aging infrastructure.
  Published on 2018-06-24; Source: China Business Network